Lost Money on ADMA BIOLOGICS, INC. (ADMA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

ADMA Biologics projected 20% ASCENIV revenue growth in 2025, but a short-seller report alleges the real figure was a 3% decline, with the gap driven entirely by an alleged channel stuffing scheme. NEW YORK, July 8, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP highlights the contrast between...